Cargando…
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug
PURPOSE: In order to attenuate the drug release rate, a single freeze-thaw step was previously shown to convert encapsulated drug into a single nanocrystal within each liposome vesicle. The goal of this study was to alter the nanocrystalline character, and thus the drug encapsulation state and relea...
Autores principales: | Cipolla, David, Wu, Huiying, Eastman, Simon, Redelmeier, Tom, Gonda, Igor, Chan, Hak-Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040743/ https://www.ncbi.nlm.nih.gov/pubmed/27439506 http://dx.doi.org/10.1007/s11095-016-2002-5 |
Ejemplares similares
-
Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties
por: Cipolla, David, et al.
Publicado: (2014) -
Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals
por: Cipolla, David, et al.
Publicado: (2015) -
Development of Liposomal Ciprofloxacin to Treat Lung Infections
por: Cipolla, David, et al.
Publicado: (2016) -
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
por: Serisier, David J, et al.
Publicado: (2013) -
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
por: Hamblin, Karleigh A., et al.
Publicado: (2014)